Publications by authors named "Scott N Freeman"

Claim this Profile
W
What the Orphan Drug Act has done lately for children with rare diseases: a 10-year analysis.
Chandana Thorat, Kui Xu, Scott N Freeman, Renan A Bonnel, Francesca Joseph

Pediatrics· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RhoBTB2 (DBC2) comes of age as a multifunctional tumor suppressor.
Scott N Freeman, W Douglas Cress

Cancer Biol Ther· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Orphan Drug Act and the development of stem cell-based products for rare diseases.
Scott N Freeman, Kathryn A Burke, Menfo A Imoisili, Timothy R Coté

Cell Stem Cell· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RhoBTB2 (DBC2) is a mitotic E2F1 target gene with a novel role in apoptosis.
Scott N Freeman, Yihong Ma, W Douglas Cress

J Biol Chem· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Scott N Freeman, Gerold Bepler, Eric Haura, Rebecca Sutphen, W Douglas Cress

J Natl Cancer Inst· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E2F4 deficiency promotes drug-induced apoptosis.
Yihong Ma, Scott N Freeman, W Douglas Cress

Cancer Biol Ther· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis